Abstract
There is scant controlled data to guide the use of repeat kidney biopsies to guide therapy in glomerular disease. De Rosa et al. assessed the value of a repeat biopsy during remission in estimating the risk of subsequent relapse of lupus nephritis. They demonstrated the feasibility of a per-protocol repeat biopsy study with prespecified subsequent therapy. Their results will inform the design of future studies of repeat biopsies in lupus nephritis and other kidney diseases.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 659-661 |
| Number of pages | 3 |
| Journal | Kidney international |
| Volume | 94 |
| Issue number | 4 |
| DOIs |
|
| State | Published - Oct 2018 |
Bibliographical note
Publisher Copyright:© 2018 International Society of Nephrology
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics of 'Repeat kidney biopsy for lupus nephritis: an important step forward'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS